Trials / Completed
CompletedNCT00610168
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
Evaluation of GSK Biologicals' dTpa Booster Vaccine in Young Adults 10 Years After Previous dTpa Boosting.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 20 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy and safety of repeating dTpa booster in adults 10 years after previous booster vaccination with dTpa in a prior clinical study. Only subjects who received booster vaccination in the previous clinical study are eligible for participation in this study.
Detailed description
This Protocol Posting has been updated in order to comply with FDA AA, Sep 2007.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Boostrix TM | Single booster dose of vaccine |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-04-30
- Completion
- 2008-04-30
- First posted
- 2008-02-07
- Last updated
- 2018-06-06
- Results posted
- 2017-03-30
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00610168. Inclusion in this directory is not an endorsement.